Trial intelligence / Profile preview

Posterior quadratus lumborum block ropivacaine concentration study in pediatric laparoscopic hernia surgery

ChiCTR2000034830Phase 4Not yet recruiting

Sponsor
Department of Anesthesiology, Lanzhou University Second Hospital
Start
Aug 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in inguinal hernia and hydrocele (3 arms), sponsored by Department of Anesthesiology, Lanzhou University Second Hospital. Primary endpoint: Time to first postoperative use of rescue analgesic medication. Planned start Aug 2020; status: not yet recruiting.

02

Drugs

ropivacaine
03

Conditions

inguinal herniahydrocele

Beyond the preview

Go deeper on ChiCTR2000034830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call